International Flavors & Fragrances, Inc. (IFF): reports that Andreas Fibig, a member of IFF’s board of directors since 2011, will succeed Doug Tough as CEO on Sept. 1. Tough will continue to serve as chairman of IFF’s board after Sept. 1 for a period to be determined. At such time, Fibig will assume the additional role of chairman.
Since 2008, Fibig, has served as president and chairman of Bayer HealthCare Pharmaceuticals, the pharmaceutical division of Bayer AG, where he has driven meaningful organic growth and its successful acquisition strategy. Prior to joining Bayer, Fibig held a number of positions of increasing responsibility at Pfizer Inc., including senior vice president in the US pharmaceutical operations group and as president, Latin America, Africa and Middle East. He also held positions with Pharmacia GmbH and Boehringer Ingelheim GmbH.